The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 23, 2018
Filed:
Jun. 13, 2013
Applicant:
Medical Research & Development Fund for Health Services Bnai Zion Medical Center, Haifa, IL;
Inventors:
Zahava Vadasz, Haifa, IL;
Elias Toubi, Haifa, IL;
Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 45/06 (2006.01); C07K 14/47 (2006.01); G01N 33/68 (2006.01); G01N 33/564 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1709 (2013.01); A61K 38/17 (2013.01); A61K 38/1774 (2013.01); A61K 45/06 (2013.01); G01N 33/564 (2013.01); G01N 33/68 (2013.01); G01N 2333/4703 (2013.01); G01N 2333/4716 (2013.01); G01N 2800/104 (2013.01); G01N 2800/52 (2013.01);
Abstract
The subject matter relates to Semaphorin 3A (Sema3A) and its use in treatment and prognosis of Systemic Lupus Erythematosus (SLE). Provided are, inter-alia, methods of treating a subject afflicted with SLE, comprising administering to the subject a pharmaceutical composition comprising isolated Sema3A. Further provided are methods for prognosis of SLE, comprising measuring Sema3A serum concentration in a subject in need thereof.